← Back to Search

Dental hygiene procedures for Peri-Implantitis

N/A
Waitlist Available
Led By Georgios Kotsakis, DDS, MS
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Summary

This trial is testing whether particles released from dental implants are associated with peri-implantitis, and if so, what triggers this release and how it amplifies peri-implant inflammation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks +/- 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks +/- 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Titanium Dissolution
Secondary outcome measures
Expression of pro-inflammatory cytokines in response to titanium

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Implant-specific treatmentExperimental Treatment2 Interventions
Implant brush
Group II: Tooth-borne treatmentActive Control2 Interventions
Titanium curettes
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Peri-implantitis debridement
2017
N/A
~40

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,762 Previous Clinical Trials
1,876,448 Total Patients Enrolled
1 Trials studying Peri-Implantitis
34 Patients Enrolled for Peri-Implantitis
Royalty Research Fund - University of WashingtonOTHER
1 Previous Clinical Trials
148 Total Patients Enrolled
Georgios Kotsakis, DDS, MSPrincipal InvestigatorUTHealth San Antonio
1 Previous Clinical Trials
34 Total Patients Enrolled
1 Trials studying Peri-Implantitis
34 Patients Enrolled for Peri-Implantitis
~4 spots leftby Jul 2025